QuidelOrtho Corporation

NASDAQ:QDEL

Medical - Instruments & Supplies

Healthcare
$9.57 +0.72%

+$0.09 today

Market cap
$656.62M
Beta
0.76
P/E (TTM)
-0.7
EPS (TTM)
-$17.76
52W Low $9.92High $35.58

Volume 2.13M

Average 2.35M

QDEL Cash & Equivalents

Cash on hand and highly liquid investments that can be converted to cash almost immediately.

QuidelOrtho CorporationNASDAQ: QDEL

Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026

Cash & equivalents rises 10.5% from a year ago

Cash & equivalents stood at $140.4M at the end of Q1 FY2026, up 10.5% from a year earlier and down 17.3% from the prior quarter. Over 3 fiscal years it compounded at -16.6% a year.

Context

  • Cash & equivalents amounted to 2.5% of total assets at the end of Q1 FY2026, up 0.5 pp from a year earlier.
  • Cash & equivalents increased in 1 of the last 3 fiscal years.

What to watch

Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +10.5% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$140.4M-17.3% QoQ
Last fiscal yearDec 2025
$169.8M+72.7% YoY
Year agoMar 2025
$127.1M+10.5% since
Cash & Equivalents past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+10.5%——
1 year+72.7%——
3-year CAGR-16.6%——
5-year CAGR——
10-year CAGR——

Cash & Equivalents history

USD · from the balance sheet

Latest · FY2025
169.8M USD
Year-over-year change
+72.7%
4-year CAGR
-32.2%

Cash & Equivalents vs competitors

How QDEL compares with its peers on the latest reported figures

  • QDEL's Mar 2026 cash & equivalents of $140.4M is the 7th highest of the 9 companies compared; the peer median is $429.44M.
  • Its year-over-year change of +10.5% is the 4th highest of 9, against a peer median of +1.3%.
  • Cash & equivalents amounts to 2.5% of total assets for QDEL, versus a peer median of 6.8%.
QDEL Competitors Peer median
Cash & Equivalents for QDEL and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
TMOThermo Fisher Scientific Inc.Sep 2026$5.46B +175.5%+4.9%4.8%
RVTYRevvity, Inc.Jul 2026$1.02B +3.1%+26.5%8.5%
DGXQuest Diagnostics IncorporatedSep 2026$797M +84.5%+10.1%4.6%
BIOBio-Rad Laboratories, Inc.Jun 2026$517M +40.0%+7.0%5.0%
OPKOPKO Health, Inc.Mar 2026$341.88M -21.6%+34.1%18.4%
OSUROraSure Technologies, Inc.Mar 2026$176.96M -28.5%+33.4%46.7%
QDELQuidelOrtho CorporationMar 2026$140.4M +10.5%-16.6%2.5%
NNNNAnbio Biotechnology Class A Ordinary SharesDec 2025$7.77M -34.0%+3.0%25.7%
TRIBTrinity Biotech plcDec 2025$5.14M -0.6%-7.9%4.9%
Peer median (excluding QDEL) $429.44M+1.3%+8.5%6.8%

Competitors are the stored peer set for QDEL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Jan 2023
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents802.8M292.9M118.9M98.3M169.8M
Short-term Investments25.7M52.1M48.4M032.4M
Net Receivables393.8M586.4M488.4M451.3M417M
Inventory198.8M524.1M577.8M533.7M577.6M
Other Current Assets4.6M22.9M10M58.3M0
Total Current Assets1.44B1.58B1.31B1.22B1.45B
Property, Plant & Equipment (Net)476.8M1.52B1.61B1.55B1.51B
Goodwill337M2.48B2.49B649.5M0
Intangible Assets98.7M3.12B2.93B2.74B2.56B
Long-term Investments37.9M21M7.4M21.7M0
Tax Assets20.1M16.4M25.9M00
Other Non-current Assets19.6M122.7M179.6M249M244.4M
Total Non-current Assets990.1M7.28B7.25B5.2B4.32B
Total Assets2.43B8.86B8.56B6.42B5.77B
Account Payables101.5M283.3M294.8M246M279.4M
Short-term Debt300K207.5M139.8M341.8M178.3M
Tax Payables77.1M51.6M29M5.4M11.5M
Deferred Revenue1.9M76.4M36.8M33.5M37.8M
Other Current Liabilities65.5M156.4M127.8M96.8M164.3M
Total Current Liabilities323.5M1.01B833.8M998.8M966.1M
Long-term Debt400K2.43B2.27B2.14B2.47B
Deferred Tax Liabilities0213.2M192.2M76.5M90M
Deferred Revenue (Non-current)09.4M017.3M0
Other Non-current Liabilities48.5M74.4M83.6M38M166.4M
Total Non-current Liabilities177.5M2.91B2.72B2.44B2.88B
Total Liabilities501M3.92B3.56B3.44B3.85B
Common Stock00100K100K100K
Retained Earnings1.65B2.2B2.19B135.8M(996M)
Accumulated OCI400K(67.6M)(30M)(36.2M)(15.4M)
Other Stockholders Equity00000
Minority Interest00000
Total Equity1.93B4.93B5.01B2.98B1.92B
Total Debt139.3M2.85B2.61B2.68B2.83B
Net Debt(663.5M)2.56B2.5B2.58B2.66B

QuidelOrtho Corporation

NASDAQ:QDEL

Intrinsic Alpha fair value

Locked

Current Price

$9.57

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.